Posted on 8/31/20
Is Quest Diagnostics a Great Dividend Stock?
To me, a great dividend stock means an investment that pays a good yield today and is likely to increase it going forward, with payouts that . . .
Posted on 8/31/20
Assembly Biosciences and Arbutus Biopharma Announce Clinical Collaboration Agreement
SOUTH SAN FRANCISCO, Calif. and WARMINSTER, Pa., Aug. 27, 2020 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB) and Arbutus Biopharma Corporation (Nasdaq: ABUS), today announced . . .
Posted on 8/28/20
Pfizer Is Out, Honeywell Is In: Should The Dow Jones Shake-Up Change Your Investing Strategy?
Three of the 30 stocks that make up the Dow Jones Industrial Average will be replaced at the end of this month. Standard & Poor's, which . . .
Posted on 8/27/20
Parker Health Group Teams Up with AARP Foundation
Parker Health Group Inc. (parkerlife.org) has provided a grant of $170,000 to AARP Foundation to implement Connect2Affect Connected Communities in 13 New Jersey affordable senior housing . . .
Posted on 8/27/20
3 Green Flags for Pfizer's Future
COVID-19 is both contagious and deadly, and when a vaccine becomes available, billions of people worldwide may need to take it if economies are to reopen . . .
Posted on 8/27/20
Pfizer Says It Has Over 50% Enrollment for Coronavirus Vaccine Candidate Trial
One of the leading COVID-19 vaccine candidates currently in development is getting closer to a potential finish line. Pfizer (NYSE:PFE) said on Wednesday that the recruitment . . .
Posted on 8/26/20
Children's Hospital of Philadelphia Opens Nicholas and Athena Karabots Primary Care Center in Norristown
Children's Hospital of Philadelphia (CHOP) is proud to announce the opening of the Nicholas and Athena Karabots Primary Care Center Norristown. Nicholas and Athena Karabots, local . . .
Posted on 8/26/20
Delta Dental Community Care Foundation Awards Nearly $950,000 in Grants to Pennsylvania Nonprofits
The Delta Dental Community Care Foundation has given grants to 31 organizations, totaling nearly $950,000, in Pennsylvania to provide relief amid the COVID-19 pandemic. These unrestricted . . .
Posted on 8/26/20
MetLife Investment Management Originates $6.2 Billion in Private Placement Debt For 1H 2020
WHIPPANY, N.J.--(BUSINESS WIRE)--MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE: MET), today announced it originated $6.2 billion in private placement debt . . .
Posted on 8/26/20
Inovio: A Viable Short, Falling Behind The Leaders In COVID-19 Vaccine Development
SummaryINO is up over 300% year-to-date despite the recent sell off.INO-4800 got out of the blocks quickly, but the pace of development has faded a little.INO . . .
Posted on 8/25/20
Inovio: Falling Behind The Leaders In COVID-19 Vaccine Development, A Very Viable Short
When COVID-19 reared its head, of course vaccine-maker Inovio Pharmaceuticals (INO) threw its hat into the ring, like it does with each epidemic or pandemic. Is . . .
Posted on 8/25/20
Otsuka America Pharmaceutical Purchases the Assets of Proteus Digital Health
PRINCETON, N.J.--(BUSINESS WIRE)--Otsuka America Pharmaceutical, Inc., (Otsuka) today announces that it has purchased the assets of Proteus Digital Health, Inc., including assets and intellectual property for . . .
Posted on 8/25/20
Penn State Cancer Institute Joins Caris Life Sciences' Precision Oncology Alliance
Caris Life Sciences, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that Penn State Cancer Institute has joined . . .
Posted on 8/25/20
Pfizer's Stock May Be Heading For A Big Breakout
SummaryAnalysts have been boosting earnings and revenue forecast for Pfizer.There has recently been some option suggesting the shares rise.Additionally, the technical chart indicates higher price to . . .
Posted on 8/24/20
Catalent Signs Agreement with AstraZeneca
SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and . . .
Posted on 8/24/20
Yumanity Therapeutics and Proteostasis Therapeutics Merge
Yumanity Therapeutics and Proteostasis Therapeutics, Inc. (Nasdaq: PTI) today announced that the companies have entered into a definitive merger agreement.
Posted on 8/24/20
Pfizer and BioNTech's Coronavirus Vaccine Candidate Produces Antibodies in People Up to 85 Years Old
If a vaccine does its job, it will produce a strong immune response in the patients inoculated with it -- driving the body to make antibodies . . .
Posted on 8/23/20
Harmony Biosciences Closes Its Upsized IPO
Harmony Biosciences Holdings, Inc., a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs, . . .
Posted on 8/23/20
Enzon Pharmaceuticals Anticipated Rights Offering to Existing Shareholders
CRANFORD, N.J., Aug. 21, 2020 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTC: ENZN) today announced that its Board of Directors (the “Board”) has approved a rights offering . . .
Posted on 8/21/20
Why Is Everyone Talking About Pfizer?
If you follow stock market news, chances are you have come across plenty of stories about Pfizer (NYSE:PFE) over the past three months. Pfizer is one . . .
Posted on 8/21/20
Johnson & Johnson to Launch Late-Stage Coronavirus Vaccine Trials in September
Might Johnson & Johnson (NYSE:JNJ) soon vault to the top of the coronavirus stock list?It's conceivable, as an entry on the government's list of clinical trials . . .
Posted on 8/20/20
3 Life Science and Health IT Companies Raise Funds — and One Goes Public
Harmony Biosciences, a Plymouth Meeting-based pharmaceutical company that develops and commercializes therapies
Posted on 8/19/20
Harmony Biosciences Announces Pricing Of Upsized Initial Public Offering
Harmony Biosciences Holdings, Inc., a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs, . . .
Posted on 8/19/20
Johnson & Johnson to Acquire Momenta Pharmaceuticals for $6.5B
Johnson & Johnson (NYSE:JNJ) today announced it has entered into a definitive agreement to acquire Momenta Pharmaceuticals, Inc., a company that discovers and develops novel therapies
Posted on 8/19/20
J&J To Acquire Momenta Pharmaceuticals For $6.5B
Johnson & Johnson (NYSE:JNJ) has agreed to acquire Momenta Pharmaceuticals (NASDAQ:MNTA) for $52.50 per share in cash for a total of $6.5B.
Philadelphia
